Cargando…
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682473/ https://www.ncbi.nlm.nih.gov/pubmed/38012151 http://dx.doi.org/10.1038/s41408-023-00950-3 |
| _version_ | 1785150983406354432 |
|---|---|
| author | Chakraborty, Rajshekhar Bhutani, Divaya Maurer, Mathew S. Mohan, Meera Lentzsch, Suzanne D’Souza, Anita |
| author_facet | Chakraborty, Rajshekhar Bhutani, Divaya Maurer, Mathew S. Mohan, Meera Lentzsch, Suzanne D’Souza, Anita |
| author_sort | Chakraborty, Rajshekhar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10682473 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106824732023-11-30 Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis Chakraborty, Rajshekhar Bhutani, Divaya Maurer, Mathew S. Mohan, Meera Lentzsch, Suzanne D’Souza, Anita Blood Cancer J Correspondence Nature Publishing Group UK 2023-11-27 /pmc/articles/PMC10682473/ /pubmed/38012151 http://dx.doi.org/10.1038/s41408-023-00950-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Chakraborty, Rajshekhar Bhutani, Divaya Maurer, Mathew S. Mohan, Meera Lentzsch, Suzanne D’Souza, Anita Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title | Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title_full | Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title_fullStr | Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title_full_unstemmed | Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title_short | Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| title_sort | safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682473/ https://www.ncbi.nlm.nih.gov/pubmed/38012151 http://dx.doi.org/10.1038/s41408-023-00950-3 |
| work_keys_str_mv | AT chakrabortyrajshekhar safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis AT bhutanidivaya safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis AT maurermathews safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis AT mohanmeera safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis AT lentzschsuzanne safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis AT dsouzaanita safetyandefficacyofteclistamabinsystemicimmunoglobulinlightchainamyloidosis |